Skip to main content
Top
Published in: Journal of Neurology 7/2007

Open Access 01-07-2007 | ORIGINAL COMMUNICATION

Fatigue: an important feature of late-onset Pompe disease

Authors: M. L. C. Hagemans, S. P. M. van Schie, A. C. J. W. Janssens, P. A. van Doorn, A. J. J. Reuser, A. T. van der Ploeg

Published in: Journal of Neurology | Issue 7/2007

Login to get access

Abstract

Objective

To investigate the prevalence and severity of fatigue in adult patients with Pompe disease.

Methods

The Fatigue Severity Scale (FSS) was assessed in an international population of 225 adults with Pompe disease, a metabolic disorder presenting as a slowly progressive proximal myopathy. The FSS scores were compared to those of healthy controls and the relationship between the level of fatigue and other patient characteristics was investigated.

Results

The mean age of the participants was 47 (SD 13) years and the mean disease duration 11 (SD 8) years. 43% used a wheelchair and 46% had respiratory support, 29% needed both. 67% of the participants had a FSS score ≥5, indicating severe fatigue. The mean FSS score was 5.2 (SD 1.5), which was significantly higher than that of healthy controls (p < 0.001). Fatigue was not related to age, sex or disease duration. Patients who used a wheelchair or respiratory support were on average more fatigued than those who did not (p = 0.01). However, of the patients who did not use these aids, 59% also had a FSS score ≥5. FSS scores were highest among patients who reported a high frequency of sleep disorders, but patients who never experienced sleep difficulties were also fatigued (mean FSS score = 4.8).

Conclusion

Fatigue is highly prevalent among both mildly and severely affected adult patients with Pompe disease. The FSS appears a useful tool in assessing fatigue in Pompe disease.
Literature
1.
go back to reference Bardwell WA, Moore P, Ancoli-Israel S, Dimsdale JE (2003) Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? Am J Psychiatry 160:350–355CrossRefPubMed Bardwell WA, Moore P, Ancoli-Israel S, Dimsdale JE (2003) Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? Am J Psychiatry 160:350–355CrossRefPubMed
2.
go back to reference Buck D, Jacoby A, Baker GA, Ley H, Steen N (1999) Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res 8:675–685CrossRefPubMed Buck D, Jacoby A, Baker GA, Ley H, Steen N (1999) Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res 8:675–685CrossRefPubMed
4.
go back to reference Demey HE, Van Meerbeeck JP, Vandewoude MF, Prove AM, Martin JJ, Bossaert LL (1989) Respiratory insuf- ficiency in acid maltase deficiency: the effect of high protein diet. JPEN J Parenter Enteral Nutr 13:321–323CrossRefPubMed Demey HE, Van Meerbeeck JP, Vandewoude MF, Prove AM, Martin JJ, Bossaert LL (1989) Respiratory insuf- ficiency in acid maltase deficiency: the effect of high protein diet. JPEN J Parenter Enteral Nutr 13:321–323CrossRefPubMed
5.
go back to reference Dimeo F, Stieglitz RD, Novelli-Fischer U, Fetscher S, Mertelsmann R, Keul J (1997) Correlation between physical performance and fatigue in cancer patients. Ann Oncol 8:1251–1255CrossRefPubMed Dimeo F, Stieglitz RD, Novelli-Fischer U, Fetscher S, Mertelsmann R, Keul J (1997) Correlation between physical performance and fatigue in cancer patients. Ann Oncol 8:1251–1255CrossRefPubMed
6.
go back to reference Dittner AJ, Wessely SC, Brown RG (2004) The assessment of fatigue. A practical guide for clinicians and researchers. J Psychosom Res 56:157–170CrossRefPubMed Dittner AJ, Wessely SC, Brown RG (2004) The assessment of fatigue. A practical guide for clinicians and researchers. J Psychosom Res 56:157–170CrossRefPubMed
7.
go back to reference Engel A, Hirschhorn R (1994) Acid maltase deficiency. In: Engel A, Franzini-Armstrong C (eds) Myology, 2nd ed. McGraw-Hill, New York, pp 1533–1553 Engel A, Hirschhorn R (1994) Acid maltase deficiency. In: Engel A, Franzini-Armstrong C (eds) Myology, 2nd ed. McGraw-Hill, New York, pp 1533–1553
8.
go back to reference Flachenecker P, Kumpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, Trenkwalder C, Toyka KV (2002) Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 8:523–526CrossRefPubMed Flachenecker P, Kumpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, Trenkwalder C, Toyka KV (2002) Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 8:523–526CrossRefPubMed
9.
go back to reference Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P (2004) Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler 10:165–169CrossRefPubMed Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P (2004) Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler 10:165–169CrossRefPubMed
10.
go back to reference Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, Van Doorn PA (2004) Physical training and fatigue, fitness, and quality of life in Guillain-Barre syndrome and CIDP. Neurology 63:2393–22395PubMed Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, Van Doorn PA (2004) Physical training and fatigue, fitness, and quality of life in Guillain-Barre syndrome and CIDP. Neurology 63:2393–22395PubMed
11.
go back to reference Hagemans ML, Janssens AC, Winkel LP, Sieradzan KA, Reuser AJ, Van Doorn PA, Van der Ploeg AT (2004) Late-onset Pompe disease primarily affects quality of life in physical health domains. Neurology 63:1688–1692PubMed Hagemans ML, Janssens AC, Winkel LP, Sieradzan KA, Reuser AJ, Van Doorn PA, Van der Ploeg AT (2004) Late-onset Pompe disease primarily affects quality of life in physical health domains. Neurology 63:1688–1692PubMed
12.
go back to reference Hagemans ML, Winkel LP, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, Van der Ploeg AT (2005) Clinical manifestation and natural course of late-onset Pompe’s disease in 54 Dutch patients. Brain 128:671–677CrossRef Hagemans ML, Winkel LP, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, Van der Ploeg AT (2005) Clinical manifestation and natural course of late-onset Pompe’s disease in 54 Dutch patients. Brain 128:671–677CrossRef
13.
go back to reference Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT (2005) Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 64:2139–2141CrossRefPubMed Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT (2005) Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 64:2139–2141CrossRefPubMed
14.
go back to reference Hayes W (1988) Statistics, 4th ed. Holt, Rinehart and Winston, Inc., Orlando Hayes W (1988) Statistics, 4th ed. Holt, Rinehart and Winston, Inc., Orlando
15.
go back to reference Herlofson K, Larsen JP (2002) Measuring fatigue in patients with Parkinson’s disease—the Fatigue Severity Scale. Eur J Neurol 9:595–600CrossRefPubMed Herlofson K, Larsen JP (2002) Measuring fatigue in patients with Parkinson’s disease—the Fatigue Severity Scale. Eur J Neurol 9:595–600CrossRefPubMed
16.
go back to reference Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II; acid aglucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th ed. McGraw-Hill, New York, pp 3389–3420 Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II; acid aglucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th ed. McGraw-Hill, New York, pp 3389–3420
17.
go back to reference Horemans HL, Nollet F, Beelen A, Lankhorst GJ (2004) A comparison of 4 questionnaires to measure fatigue in postpoliomyelitis syndrome. Arch Phys Med Rehabil 85:392–398CrossRefPubMed Horemans HL, Nollet F, Beelen A, Lankhorst GJ (2004) A comparison of 4 questionnaires to measure fatigue in postpoliomyelitis syndrome. Arch Phys Med Rehabil 85:392–398CrossRefPubMed
18.
go back to reference Kleinman L, Zodet MW, Hakim Z, Aledort J, Barker C, Chan K, Krupp L, Revicki D (2000) Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 9:499–508CrossRefPubMed Kleinman L, Zodet MW, Hakim Z, Aledort J, Barker C, Chan K, Krupp L, Revicki D (2000) Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 9:499–508CrossRefPubMed
19.
go back to reference Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123PubMed Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123PubMed
20.
go back to reference Matsuishi T, Terasawa K, Yoshida I, Yano E, Yamashita F, Hidaka T, Ishihara O, Yoshino M, Nonaka I, Kurokawa T, Nakamura Y (1982) Vacuolar myopathy with type 2 A fiber atrophy and type 2 B fiber deficiency. A case of childhood form acid alpha-1,4- glucosidase deficiency. Neuropediatrics 13:173–176CrossRefPubMed Matsuishi T, Terasawa K, Yoshida I, Yano E, Yamashita F, Hidaka T, Ishihara O, Yoshino M, Nonaka I, Kurokawa T, Nakamura Y (1982) Vacuolar myopathy with type 2 A fiber atrophy and type 2 B fiber deficiency. A case of childhood form acid alpha-1,4- glucosidase deficiency. Neuropediatrics 13:173–176CrossRefPubMed
21.
go back to reference Mellies U, Stehling F, Dohna-Schwake C, Ragette R, Teschler H, Voit T (2005) Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology 64:1465–1467PubMed Mellies U, Stehling F, Dohna-Schwake C, Ragette R, Teschler H, Voit T (2005) Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology 64:1465–1467PubMed
22.
go back to reference Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA (1999) Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 53:1648–1654PubMed Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA (1999) Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 53:1648–1654PubMed
23.
go back to reference Mobarhan S, Pintozzi RL, Damle P, Friedman H (1990) Treatment of acid maltase deficiency with a diet high in branched-chain amino acids. JPEN J Parenter Enteral Nutr 14:210–212CrossRefPubMed Mobarhan S, Pintozzi RL, Damle P, Friedman H (1990) Treatment of acid maltase deficiency with a diet high in branched-chain amino acids. JPEN J Parenter Enteral Nutr 14:210–212CrossRefPubMed
24.
go back to reference Nunnally JC, Bernstein IH (1994) Psychometric theory, 3rd ed. McGraw-Hill, New York Nunnally JC, Bernstein IH (1994) Psychometric theory, 3rd ed. McGraw-Hill, New York
25.
go back to reference Pellegrini N, Laforet P, Orlikowski D, Pellegrini M, Caillaud C, Eymard B, Raphael J-C, Lofaso F (2005) Respiratory insufficiency and limb muscle weakness in adults with Pompe’s disease. Eur Respir J 26:1024–1031CrossRefPubMed Pellegrini N, Laforet P, Orlikowski D, Pellegrini M, Caillaud C, Eymard B, Raphael J-C, Lofaso F (2005) Respiratory insufficiency and limb muscle weakness in adults with Pompe’s disease. Eur Respir J 26:1024–1031CrossRefPubMed
26.
go back to reference Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW (1996) Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39:432–441CrossRefPubMed Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW (1996) Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39:432–441CrossRefPubMed
27.
go back to reference Sivak ED, Ahmad M, Hanson MR, Mitsumoto H, Wilbourn AJ (1987) Respiratory insufficiency in adult-onset acid maltase deficiency. South Med J 80:205–208CrossRefPubMed Sivak ED, Ahmad M, Hanson MR, Mitsumoto H, Wilbourn AJ (1987) Respiratory insufficiency in adult-onset acid maltase deficiency. South Med J 80:205–208CrossRefPubMed
28.
go back to reference Van den Hout JMP, Hop W, Van Diggelen OP, Smeitink JA, Smit GP, Poll- The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, Van der Ploeg AT (2003) The natural course of infantile Pompe’s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332–340CrossRefPubMed Van den Hout JMP, Hop W, Van Diggelen OP, Smeitink JA, Smit GP, Poll- The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, Van der Ploeg AT (2003) The natural course of infantile Pompe’s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332–340CrossRefPubMed
29.
go back to reference Van der Ploeg AT (2005) Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives. Eur Respir J 26:984–985CrossRefPubMed Van der Ploeg AT (2005) Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives. Eur Respir J 26:984–985CrossRefPubMed
30.
go back to reference Winkel LP, Van den Hout JM, Kamphoven JH, Disseldorp JA, Remmerswaal M, Arts WF, Loonen MCB, Vulto AG, Van Doorn PA, De Jong GD, Hop W, Smit GPA, Shapira SK, Van Diggelen OP, Boer MA, Reuser AJJ, Van der Ploeg AT (2004) Enzyme replacement therapy in lateonset Pompe’s disease: a three-year follow-up. Ann Neurol 55:495–402CrossRefPubMed Winkel LP, Van den Hout JM, Kamphoven JH, Disseldorp JA, Remmerswaal M, Arts WF, Loonen MCB, Vulto AG, Van Doorn PA, De Jong GD, Hop W, Smit GPA, Shapira SK, Van Diggelen OP, Boer MA, Reuser AJJ, Van der Ploeg AT (2004) Enzyme replacement therapy in lateonset Pompe’s disease: a three-year follow-up. Ann Neurol 55:495–402CrossRefPubMed
31.
go back to reference Winkel LPF, Hagemans MLC, van Doorn PA, Loonen MCB, Hop WJC, Reuser AJJ, van der Ploeg AT (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252:875–884CrossRefPubMed Winkel LPF, Hagemans MLC, van Doorn PA, Loonen MCB, Hop WJC, Reuser AJJ, van der Ploeg AT (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252:875–884CrossRefPubMed
32.
go back to reference Wokke JH, Ausems MG, Van den Boogaard MJ, Ippel EF, van Diggelen O, Kroos MA, Boer M, Jennekens FG, Reuser AJ, Ploos van Amstel HK (1995) Genotype-phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol 38:450–454CrossRefPubMed Wokke JH, Ausems MG, Van den Boogaard MJ, Ippel EF, van Diggelen O, Kroos MA, Boer M, Jennekens FG, Reuser AJ, Ploos van Amstel HK (1995) Genotype-phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol 38:450–454CrossRefPubMed
33.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
Metadata
Title
Fatigue: an important feature of late-onset Pompe disease
Authors
M. L. C. Hagemans
S. P. M. van Schie
A. C. J. W. Janssens
P. A. van Doorn
A. J. J. Reuser
A. T. van der Ploeg
Publication date
01-07-2007
Publisher
Steinkopff-Verlag
Published in
Journal of Neurology / Issue 7/2007
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-006-0434-2

Other articles of this Issue 7/2007

Journal of Neurology 7/2007 Go to the issue